ORKA Q3 2021 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$27,000

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-3.92

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$60M

Total Liabilities

$4M

Stockholders' Equity

$57M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$27,000	-$26,000	-3.8%
Operating Income	-$5M	-$2M	-137.0%
Net Income	-$5M	-$2M	-136.7%